GUILD Learning and Development is partnering with vaccine manufacturer, Seqirus, to develop a new training course titled Influenza vaccines: now and future advances.
The Australian Pharmacy Council accredited program aims to increase pharmacists' confidence in both recommending and providing advice on the flu vaccine, including Seqirus' cell-based vaccines, which are being rolled out in Australia for the first time this year.
The module has been approved for 0.75 hours of Group 1 CPD, which can be converted to 0.75 hours of Group 2 CPD on completion of relevant assessments.
CLICK HERE for more.
The above article was sent to subscribers in Pharmacy Daily's issue from 09 Apr 21
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Apr 21